IUC26686-93

Abstract Code: IUC26686-93   Synergistic potential of cabozantinib and radiotherapy in advanced renal cell carcinoma by site of irradiation Di Costanzo 1, A. Bertocchi 2, M.L. Esposito 3, I.S. Parisi 4, A. Federico 2, P.A. Zucali 2, L. Formisano 3, C. Oing 1, R....

IUC26684-91

Abstract Code: IUC26684-91   Real world outcomes of immune checkpoint inhibitors in metastatic renal cell cancer(mRCC) from a tertiary care cancer centre in South India M.S. Chandrasekaran 1, P. Thamaraiselvan 1, A. Raja 1, V. Radhakrishnan 1 (1) Cancer Institute...

IUC26682-89

Abstract Code: IUC26682-89   Efficacy and tolerability of immune checkpoint inhibitors in older versus younger patients with metastatic renal cell carcinoma: a real-world Asian cohort Kanesvaran 1, H.S. Tan 1, J.W.K. Chan 1, W.C. Tan 1, D.J.M. Ang 1, J.J.X. Tan...

IUC26678-94

Abstract Code: IUC26678-94   Impact of Metastatic Patterns on First-Line Therapy in mRCC: Meet-URO 33 Peretto 1, S.E. Rebuzzi 2, E. Verzoni 3, S. Buti 4, M. Di Napoli 5, C. Lolli 6, M. Fanelli 7, C. Masini 8, P.A. Zucali 9, A. Mennitto 10, M. Sorarù 11, R....

IUC26672-88

Abstract Code: IUC26672-88   Treatment beyond progression in primary refractory mRCC during 1L systemic therapy (Meet-Uro 33) Aspden 1, D. Bimbatti 2, A. Dalla Volta 3, G. Roviello 4, R. Iacovelli 5, G. Bozza 6, M.G. Vitale 7, E. Fantinel 8, A. Guida 9, F.M....

IUC26671-87

Abstract Code: IUC26671-87   Adjuvant Pembrolizumab in RCC: Real world experience in Northern Ireland 2022-2026 Buchanan 1, G. Clements 1, C. Forde 1, A. Clayton 1 (1) Northern Ireland cancer centre, Belfast – United Kingdom   Objective: Adjuvant...
error: Content is protected !!